Interleukin-2 in the treatment of hematologic malignancies

Cancer Journal

Volumn 6, Issue SUPPL. 1, 2000, Pages

  Fefer, A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2;

BLOOD DISEASE; CLINICAL TRIAL; EDITORIAL; HUMAN; LYMPHOKINE ACTIVATED KILLER CELL; MALIGNANT NEOPLASTIC DISEASE; MINIMAL RESIDUAL DISEASE; NONHUMAN; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; ACUTE GRANULOCYTIC LEUKEMIA; CANCER IMMUNOTHERAPY; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; HEMATOPOIETIC STEM CELL TRANSPLANTATION;

CLINICAL TRIALS; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERLEUKIN-2;

EID: 0033840007     PISSN: 15289117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (3)

1. Interleukin-2: Clinical applications to hematologic malignancies
2. Children's Cancer Group trials of interleukin-2 therapy to prevent relapse of acute myelogenous leukemia
3. Immunotherapy with interleukin-2 after hematopoietic cell transplantation for hematologic malignancy